School of Medicine
Showing 1-10 of 43 Results
Lucy Erin O'Brien
Assistant Professor of Molecular and Cellular Physiology
Current Research and Scholarly Interests Many adult organs tune their functional capacity to variable levels of physiologic demand. Adaptive organ resizing breaks the allometry of the body plan that was established during development, suggesting that it occurs through different mechanisms. Emerging evidence points to stem cells as key players in these mechanisms. We use the Drosophila midgut, a stem-cell based organ analogous to the vertebrate small intestine, as a simple model to uncover the rules that govern adaptive remodeling.
Associate Professor of Psychiatry and Behavioral Sciences (VA Geriatric)
Current Research and Scholarly Interests Dr. O’Hara’s research aims to identify physiological markers of neurocognitive impairment in a broad range of late-life disorders, including Mild Cognitive Impairment, Alzheimer’s disease (AD), Late-Life Depression, and Late-Life Anxiety disorders.
Michelle O'Shaughnessy, MD, MRCPI, MS
Clinical Assistant Professor, Medicine - Nephrology
Bio Dr. Michelle O'Shaughnessy specializes in the treatment of kidney disease and hypertension. She practiced Internal Medicine and Nephrology for 4 years in Ireland before coming to Stanford in 2013 to complete a 3-year Clinical Research Fellowship in nephrology. Dr. O'Shaughnessy has a special interest in treating and studying patients with glomerular diseases i.e. those diseases that affect the glomerulus (or filtering portion) of the kidney.
Professor of Surgery at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly Interests Trauma, especially splenic and thoracic
Consulting Assistant Professor, Health Research & Policy
Current Research and Scholarly Interests Evaluating factors associated with gene/environment interactions and disparities in prostate, thyroid, ovary and breast cancer diagnosis and survival.
Working with communities for solutions to reduce cancer and reduce the chances of cancer progression.
Collecting and utilizing comprehensive data that includes biomarkers and biosensor input in behavioral interventions to decrease cancer occurrence and improve survival.
Leveraging mobile health to prevent cancer and improve life after treatment